<html>
<head>PUBMED IDs for MAP6</head>
<body bgcolor='#C5F0F2'><h1>MAP6</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10516426/'>Assignment of the STOP gene (MAP6) to human chromosome bands 6p12--&gt;p11 by fluorescence in situ hybridization.</a> October 12  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/16624526/'>Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia.</a> April 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18462827/'>Dysregulation of GIMAP genes in non-small cell lung cancer.</a> May 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18462824/'>Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload.</a> May 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19016712/'>GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.</a> November 20  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19016711/'>Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.</a> November 20  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21902667/'>Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).</a> March 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24357581/'>The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes.</a> April 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25484074/'>New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27667392/'>Dysregulation of GTPase IMAP family members in hepatocellular cancer.</a> September 27  2016<br></body></html>
